Emily Jones is professor of translational neurodevelopment at the Centre for Brain and Cognitive Development at Birkbeck, University of London in the United Kingdom. Her research efforts center on the neurodevelopmental pathways that lead to autism. She is involved with a number of early-intervention studies for infants with siblings with autism and attention deficit hyperactivity disorder.
Emily Jones
Professor
Birkbeck, University of London
From this contributor
Connecting autism-linked genetic variation to infant social behavior
Integrating genetic analyses into studies of babies’ brain development could help us understand how autism-related genes contribute to autism traits.
Connecting autism-linked genetic variation to infant social behavior
By
Anna Gui, Emily Jones
10 August 2021 | 5 min read
Explore more from The Transmitter
Watching the mind build a world: Lucid dreaming as a model for generative perception
Lucid dreaming offers a rare opportunity to observe and probe perception from within.
Watching the mind build a world: Lucid dreaming as a model for generative perception
Lucid dreaming offers a rare opportunity to observe and probe perception from within.
By
Magdalena Paluchowska
13 July 2026 | 8 min read
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
By
Natalia Mesa
9 July 2026 | 5 min read
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read